Researchers from Winship Cancer Institute of Emory University will present emerging pre-clinical, epidemiological and clinical data in blood cancers and blood disorders at the 66th Annual Meeting of the American Society of Hematology (ASH) in San Diego, Dec. 7-10, 2024.
With more than 18,000 members from nearly 100 countries, ASH is the world’s largest professional society serving clinicians and scientists who are working to make progress against blood diseases. Its annual meeting, recognized as the premier global hematology conference, drew over 32,000 attendees last year.
From chairing symposia to presenting promising new treatment approaches for blood malignancies and benign blood diseases, Winship investigators will participate in 80 sessions, beginning with pre-conference workshops and symposia on Dec. 6. Oral and poster presentations will describe new insights and advances from Winship teams and colleagues from Emory University School of Medicine, Georgia Institute of Technology, Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and collaborators from around the world.
“Emory’s contributions to the ASH Annual Meeting are notable, with a significant number of high-impact presentations as well as major sessions moderated and led by our faculty,” said Winship physician-researcher David A. Frank, MD, PhD, director of the Division of Hematology in Emory University School of Medicine’s Department of Hematology and Medical Oncology. “Our physician-researchers, scientists and advance practice providers are presenting on discoveries they’ve led in advancing the treatment of blood cancers and other blood disorders. Our medical students and graduate students will deliver presentations as well, showcasing our role in training the next generation of hematologists.”